Mobile

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic ...

Update Il y a 5 ans
Reference: EUCTR2010-020150-34

A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Main objective: To assess the safety and tolerability of inactivated VZV vaccine in recipients of autologous HCT and to assess the impact of inactivated VZV vaccine on the development of HZ following autologous HCT

Inclusion criteria

  • Incidence of Herpes Zoster in recipients of Autologous HCTs

Links